Janus Henderson Group plc 13D and 13G filings for Janux Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-14 11:26 am Sale | 2025-06-30 | 13G | Janux Therapeutics, Inc. JANX | JANUS HENDERSON GROUP PLC JHG | 4,460,332 7.500% | -138,205 (-3.01%) | Filing |
| 2025-05-14 12:25 pm Purchase | 2025-03-31 | 13G | Janux Therapeutics, Inc. JANX | JANUS HENDERSON GROUP PLC JHG | 4,598,537 7.800% | 1,036,135 (+29.09%) | Filing |
| 2025-02-14 11:24 am Purchase | 2024-12-31 | 13G | Janux Therapeutics, Inc. JANX | JANUS HENDERSON GROUP PLC JHG | 3,562,402 6.100% | 1,724,611 (+93.84%) | Filing |
| 2023-02-09 11:40 am Sale | 2022-12-31 | 13G | Janux Therapeutics, Inc. JANX | JANUS HENDERSON GROUP PLC JHG | 1,837,791 4.400% | -563,102 (-23.45%) | Filing |
| 2022-02-11 6:30 pm Purchase | 2021-12-31 | 13G | Janux Therapeutics, Inc. JANX | JANUS HENDERSON GROUP PLC JHG | 2,400,893 5.800% | 2,400,893 (New Position) | Filing |